Search research articles
Contact Us
Filters
Showing results (11-20 of 29) with videos related to
Page
of 3
Sort By:
Drug Metabolism and Disposition: the Biological Fate of Chemicals
|
October 9, 1997
Bioactivation of the anticancer agent CPT-11 to SN-38 by human hepatic microsomal carboxylesterases and the in vitro assessment of potential drug interactions
J G Slatter, P Su, J P Sams, et al.
European Journal of Clinical Pharmacology
|
January 1, 1987
Influence of smoking and gender on the disposition kinetics of metoprolol
L J Schaaf, S C Campbell, M B Mayersohn, et al.
Journal of Chromatography
|
August 9, 1985
Analysis of 5'-deoxy-5-fluorouridine and 5-fluorouracil in human plasma and urine by high-performance liquid chromatography
L J Schaaf, D G Ferry, C T Hung, et al.
The Annals of Pharmacotherapy
|
November 1, 1995
Evaluation of the pharmacokinetic interaction between cimetidine or famotidine and cyclosporine in healthy men
M S Shaefer, S J Rossi, T R McGuire, et al.
American Journal of Hospital Pharmacy
|
July 1, 1990
Stability of esmolol hydrochloride in the presence of aminophylline, bretylium tosylate, heparin sodium, and procainamide hydrochloride
L J Schaaf, D H Robinson, G J Vogel, et al.
Journal of Chromatography
|
January 14, 1994
Fully automated high-performance liquid chromatographic method for the determination of carzelesin (U-80,244) and metabolites (U-76,073 and U-76,074) in human plasma
O van Tellingen, E M Pels, R E Henrar, et al.
Cancer Research
|
June 11, 1998
Comparative pharmacology of the novel cyclopropylpyrroloindole-prodrug carzelesin in mice, rats, and humans
O van Tellingen, W J Nooijen, L J Schaaf, et al.
Cancer Chemotherapy and Pharmacology
|
September 17, 2008
Phase I and pharmacokinetic study of mitomycin C and celecoxib as potential modulators of tumor resistance to irinotecan in patients with solid malignancies
Y Xu, J M Kolesar, L J Schaaf, et al.
Cancer Chemotherapy and Pharmacology
|
April 2, 1998
A clinical pharmacokinetics study of carzelesin given by short-term intravenous infusion in a phase I study
O van Tellingen, C J Punt, A Awada, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 24, 1999
Phase II study of irinotecan plus cisplatin in patients with advanced non-small-cell lung cancer
R F DeVore, D H Johnson, J Crawford, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 29) with videos related to
Sort By:
Page
of 3
Drug Metabolism and Disposition: the Biological Fate of Chemicals
|
October 9, 1997
Bioactivation of the anticancer agent CPT-11 to SN-38 by human hepatic microsomal carboxylesterases and the in vitro assessment of potential drug interactions
J G Slatter, P Su, J P Sams, et al.
European Journal of Clinical Pharmacology
|
January 1, 1987
Influence of smoking and gender on the disposition kinetics of metoprolol
L J Schaaf, S C Campbell, M B Mayersohn, et al.
Journal of Chromatography
|
August 9, 1985
Analysis of 5'-deoxy-5-fluorouridine and 5-fluorouracil in human plasma and urine by high-performance liquid chromatography
L J Schaaf, D G Ferry, C T Hung, et al.
The Annals of Pharmacotherapy
|
November 1, 1995
Evaluation of the pharmacokinetic interaction between cimetidine or famotidine and cyclosporine in healthy men
M S Shaefer, S J Rossi, T R McGuire, et al.
American Journal of Hospital Pharmacy
|
July 1, 1990
Stability of esmolol hydrochloride in the presence of aminophylline, bretylium tosylate, heparin sodium, and procainamide hydrochloride
L J Schaaf, D H Robinson, G J Vogel, et al.
Journal of Chromatography
|
January 14, 1994
Fully automated high-performance liquid chromatographic method for the determination of carzelesin (U-80,244) and metabolites (U-76,073 and U-76,074) in human plasma
O van Tellingen, E M Pels, R E Henrar, et al.
Cancer Research
|
June 11, 1998
Comparative pharmacology of the novel cyclopropylpyrroloindole-prodrug carzelesin in mice, rats, and humans
O van Tellingen, W J Nooijen, L J Schaaf, et al.
Cancer Chemotherapy and Pharmacology
|
September 17, 2008
Phase I and pharmacokinetic study of mitomycin C and celecoxib as potential modulators of tumor resistance to irinotecan in patients with solid malignancies
Y Xu, J M Kolesar, L J Schaaf, et al.
Cancer Chemotherapy and Pharmacology
|
April 2, 1998
A clinical pharmacokinetics study of carzelesin given by short-term intravenous infusion in a phase I study
O van Tellingen, C J Punt, A Awada, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 24, 1999
Phase II study of irinotecan plus cisplatin in patients with advanced non-small-cell lung cancer
R F DeVore, D H Johnson, J Crawford, et al.
Page
of 3